Chronic noncommunicable diseases: focus on multimorbid pathological conditions and cardiovascular risk
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 1
Abstract
Objective — to assess the structure of multimorbidity among common chronic noncommunicable diseases (NCD) in Kharkiv region. Materials and methods. The screening has been performed among patients (n = 1428) with increased cardiovascular risk (CVR) with multimorbidity; the mean age of patients (58.41 ± 8.12) years; from them 512 (35.85 %) men and 916 (64.15 %) women. The calculation of CVR degree of was carried out according to the latest recommendations (2013, 2018) for the prevention and treatment of cardiovascular diseases (CVD); calculation of the comorbidity index was carried out according to the modern electronic modifications (2012—2017), (M.E. Charlson et al., 1987). To rectify the components of cardiometabolic risk, a retrospective study of the data (n = 191) of patients, that included 82 (42.9 %) women and 109 (57.1 %) men; the mean age (59.17 ± 1.81) years. The laboratory biochemical, clinicalinstrumental and statistical methods were used during the study. Results and discussion. At present time, CVD occupies the leading place (68 %) in the structure of mortality in the Kharkiv region, and multimorbidity is an aggravating determining factor. In the study of indicators of multimorbidity of patients with elevated CVR (n = 1428) it has been established that patients with overweight consisted the majority of this category: the mean body mass index was (30.64 ± 0.18) kg/m2. The combined condition and agerelated score was (5.98 ± 0.16) points; Charlson index of comorbidity (4.87 ± 0.18) points; tenyear survival rate was (24.94 ± 1.07) %. The increased indices correlated with the worsening of the quality of life (р < 0.001). The retrospective study (n = 191) revealed additional components of cardiometabolic risk: overweight (35.1 %), abdominal obesity (52.6 %), type 2 diabetes (37.7 %), nonalcoholic fatty liver disease (80.6 %), secondary dyslipidemia (90.6 %), hyperuricemia (41.4 %), burdened with hypertension and type 2 diabetes heredity (42.9 %) and (6.8 %), respectively) and smoking (10.5 %). A populationbased strategy for the prevention of NCD and their multimorbidity should cover a wide range of populations, including young people (where CVR may be low or moderate) and middleaged and elderly people (where CVR is high or very high). Conclusions. Multimorbidity, modified and unmodified risk factors significantly affect the prognosis and end points at high and very high СVR, and even more on the specific of disease and the effectiveness of treatment. Given the high frequency of multimorbidity among patients with NCD, the determination of the comorbidity index along with the assessment of CVR allows a more thorough approach to the participation of patients in individual and group complex therapeutic, rehabilitation and preventive measures. For modern medical practice, the problem is not the treatment of a single nosology, but the treatment of a particular patient, taking into account all possible risk factors and multimorbidity. Determining the degree of CVR, taking into account multimorbidity, is a leading step in determining the preventive strategy at the individual, family and population levels.
Authors and Affiliations
A. O. Nesen, V. A. Chernyshov, V. L. Shkapo, I. A. Valentynova
Health aging: medicalbiological and socioeconomic aspects
The review is devoted to the discussion of population, biomedical and socioeconomic aspects of aging. The data have been presented on the demographic situation in the world, due to the rapid growth of aging in the XXI c...
Influence of combination of genetic haplotype of b1- and b2-adrenoreceptors on cardiac disease
Objective — to determine the prevalence and the effects of combined haplotypes of b1- and b2-adrenoreceptors genes on the course of heart failure. Materials and methods. 200 patients with heart failure were included to s...
Significance of non-invasive assessment of the enhancing left ventricle filling pressure in patients with arterial hypertension, left ventricle hypertrophy, symptoms of heart failure and the preserved ejection fraction in real life
Objective — to estimate left ventricle filling pressure (LVFP), as indicator of heart failure (HF), in patients with arterial hypertension (AH), symptoms and signs of HF, preserved left ventricle (LV) ejection fraction (...
Macrophage migration inhibitory factor and acute myocardial infarction
Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine involved in the development of many acute and chronic inflammatory diseases, including cardiovascular diseases. A link between MIF a...
The circadian rhythms of 6-Sulfatoxymelatonin urine excretion in patients with knee osteoarthrosis
Оbjective — to establish the peculiarities of the circadian rhythms of 6-sulfatoxymelatonin (6-SMT) urine excretion in patients with knee osteoarthrosis (OA) depending on age, gender, duration and stage of the disease. M...